Trial Profile
The Activation of Brown and Beige Fat and Role in Insulin Sensitivity
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Pioglitazone (Primary)
- Indications Metabolic syndrome; Obesity
- Focus Biomarker; Pharmacodynamics
- 05 Feb 2020 Status changed from recruiting to completed.
- 24 May 2017 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 24 May 2017 Status changed from not yet recruiting to recruiting.